The safety of monoclonal antibodies for treatment of colorectal cancer-Reference-Cited by-同舟云学术

The safety of monoclonal antibodies for treatment of colorectal cancer

Published:2016-04-12 Issue:6 Volume:15 Page:799-808
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Berger Martin D.¹,Lenz Heinz-Josef¹²

Affiliation:

1. Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

2. Department of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

Publisher

Informa Healthcare

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/14740338.2016.1167186

Reference75 articles.

1. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy

2. Tumorigenesis and the angiogenic switch

3. Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015

4. Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NDRG1 enhances the sensitivity to Cetuximab by promoting Stat1 ubiquitylation in colorectal cancer;Journal of Advanced Research;2024-08

2. Recent advancements in immunotherapy for colorectal cancer;Colorectal Cancer;2024

3. Agrocybe cylindracea fucoglucogalactan induced lysosome-mediated apoptosis of colorectal cancer cell through H3K27ac-regulated cathepsin D;Carbohydrate Polymers;2023-11

4. Colorectal Cancer Liver Metastases: Genomics and Biomarkers with Focus on Local Therapies;Cancers;2023-03-09

5. Identifying and clinically validating biomarkers for immunotherapy in colorectal cancer;Expert Review of Molecular Diagnostics;2023-03-04